Thymidine Kinase Levels in Breast Cancer Patients
Author Information
Author(s): P.G. McKennal, K.L. O'Neill, W.P. Abram, B.M. Hannigan
Primary Institution: Biomedical Sciences Research Centre, University of Ulster
Hypothesis
Are thymidine kinase levels elevated in breast cancer patients compared to non-cancer controls?
Conclusion
Thymidine kinase levels are significantly higher in breast cancer patients compared to non-cancer controls, and serum levels correlate with cancer stage.
Supporting Evidence
- Serum TK levels in breast cancer patients were significantly higher than in control patients.
- Serum TK levels showed a significant correlation with cancer stage.
- Mononuclear leukocyte TK levels were also elevated in breast cancer patients.
Takeaway
Breast cancer patients have more thymidine kinase in their blood than people without cancer, and this can help doctors understand how advanced the cancer is.
Methodology
The study measured thymidine kinase levels in mononuclear leukocytes and serum from breast cancer patients and non-cancer controls using blood samples.
Limitations
The study only included patients from specific hospitals and did not account for all potential confounding factors.
Participant Demographics
70 female breast cancer patients and 175 non-cancer patients (98 males and 77 females).
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website